B Nikbin

1.3k total citations
35 papers, 1.1k citations indexed

About

B Nikbin is a scholar working on Immunology, Genetics and Rheumatology. According to data from OpenAlex, B Nikbin has authored 35 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 9 papers in Genetics and 9 papers in Rheumatology. Recurrent topics in B Nikbin's work include Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). B Nikbin is often cited by papers focused on Immunotherapy and Immune Responses (8 papers), Immune Cell Function and Interaction (6 papers) and T-cell and B-cell Immunology (6 papers). B Nikbin collaborates with scholars based in Iran, United Kingdom and United States. B Nikbin's co-authors include Fereydoun Davatchi, Mandana Mohyeddin, Bahar Sadeghi Abdollahi, Farhad Shahram, Mandana Mohyeddin Bonab, Ali Farazmand, Alireza Minagar, F. Ala, Yohei Katsuyama and Shigeru Ono and has published in prestigious journals such as SHILAP Revista de lepidopterología, Neurology and Gut.

In The Last Decade

B Nikbin

34 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
B Nikbin Iran 15 428 415 260 188 180 35 1.1k
Evy Lundgren-Åkerlund United States 19 329 0.8× 102 0.2× 224 0.9× 66 0.4× 407 2.3× 26 1.4k
Hamidreza Mahmoudi Iran 19 314 0.7× 347 0.8× 81 0.3× 192 1.0× 176 1.0× 129 1.2k
Tomoiku Takaku Japan 16 75 0.2× 198 0.5× 231 0.9× 115 0.6× 227 1.3× 70 968
Michael S. Howard United States 18 217 0.5× 231 0.6× 111 0.4× 38 0.2× 90 0.5× 104 1.0k
Nithya Lingampalli United States 17 486 1.1× 52 0.1× 427 1.6× 107 0.6× 362 2.0× 24 1.3k
Song‐Shu Lin Taiwan 18 110 0.3× 134 0.3× 140 0.5× 33 0.2× 182 1.0× 36 876
Gordon D. Wu United States 15 69 0.2× 304 0.7× 249 1.0× 58 0.3× 248 1.4× 56 1.2k
Naili An United States 6 135 0.3× 147 0.4× 45 0.2× 147 0.8× 480 2.7× 6 995
Antonio Romero Spain 14 106 0.2× 375 0.9× 67 0.3× 104 0.6× 151 0.8× 24 757
Timothy L. Weiland United States 11 128 0.3× 154 0.4× 42 0.2× 107 0.6× 216 1.2× 15 866

Countries citing papers authored by B Nikbin

Since Specialization
Citations

This map shows the geographic impact of B Nikbin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by B Nikbin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites B Nikbin more than expected).

Fields of papers citing papers by B Nikbin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by B Nikbin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by B Nikbin. The network helps show where B Nikbin may publish in the future.

Co-authorship network of co-authors of B Nikbin

This figure shows the co-authorship network connecting the top 25 collaborators of B Nikbin. A scholar is included among the top collaborators of B Nikbin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with B Nikbin. B Nikbin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Hosseini‐khah, Zahra, Mohammad Reza Babaei, Mohsen Tehrani, et al.. (2021). SOX2 and Bcl-2 as a Novel Prognostic Value in Hepatocellular Carcinoma Progression. Current Oncology. 28(4). 3015–3029. 9 indexed citations
2.
Johari, Behrooz, Akram Alizadeh, Majid Lotfinia, et al.. (2019). Enrichment of cancer stem‐like cells by the induction of epithelial‐mesenchymal transition using lentiviral vector carrying E‐cadherin shRNA in HT29 cell line. Journal of Cellular Physiology. 234(12). 22935–22946. 13 indexed citations
3.
Kadivar, Mehdi, Behrooz Johari, Majid Lotfinia, et al.. (2016). Transduction of an optimized recombinant lentivirus expressing E-cadherin shRNA resulted in stable downregulation of CDH1 gene and obvious cell morphological change in the human colorectal cancer cell line HT29. International Journal of Medical Research & Health Sciences. 5(11). 87–93. 7 indexed citations
4.
Davatchi, Fereydoun, Bahar Sadeghi Abdollahi, Mandana Mohyeddin, & B Nikbin. (2015). Mesenchymal stem cell therapy for knee osteoarthritis: 5 years follow‐up of three patients. International Journal of Rheumatic Diseases. 19(3). 219–225. 156 indexed citations
5.
Saeidi, Mohsen, Yadollah Shakiba, Jamshid Hadjati, et al.. (2013). Immunomodulatory effects of human umbilical cord Wharton's jelly-derived mesenchymal stem cells on differentiation, maturation and endocytosis of monocyte-derived dendritic cells.. PubMed. 12(1). 37–49. 28 indexed citations
6.
Davatchi, Fereydoun, Bahar Sadeghi Abdollahi, Mandana Mohyeddin, Farhad Shahram, & B Nikbin. (2011). Mesenchymal stem cell therapy for knee osteoarthritis. Preliminary report of four patients. International Journal of Rheumatic Diseases. 14(2). 211–215. 321 indexed citations
7.
Mehrsai, Abdolrasoul, et al.. (2009). The effect of low-level helium-neon (HeNe) laser radiation on the secretion of cytokines that promote chronic graft rejection – An in vitro study. Medical Laser Application. 24(3). 194–200. 5 indexed citations
8.
Jafari-Shakib, Reza, et al.. (2008). Plasma sCD26 and sCD30 levels in cutaneous leishmaniasis. Acta Tropica. 109(1). 61–63. 11 indexed citations
9.
Nicknam, Mohammad Hossein, Mahdi Mahmoudi, Ali Akbar Amirzargar, et al.. (2008). Determination of HLA-B27 subtypes in Iranian patients with ankylosing spondylitis.. PubMed. 7(1). 19–24. 32 indexed citations
10.
Minagar, Alireza, Deborah Commins, John Alexander, et al.. (2008). NeuroAIDS. Molecular Diagnosis & Therapy. 12(1). 25–43. 41 indexed citations
11.
Jafari-Shakib, Reza, Soheila Ajdary, Zahra Mohtasham‐Amiri, et al.. (2008). CD26 expression on CD4+ T cells in patients with cutaneous leishmaniasis. Clinical & Experimental Immunology. 153(1). 31–36. 11 indexed citations
12.
Amirzargar, Aliakbar, et al.. (2007). Association of HLA class II allele and haplotype frequencies with chronic myelogenous leukemia and age-at-onset of the disease. Pathology & Oncology Research. 13(1). 47–51. 14 indexed citations
13.
Bagheri, Morteza, et al.. (2005). CYTOKINE GENE POLYMORPHISMS IN IRANIAN PATIENTS WITH BETA-THALASSEMIA MAJOR. 2(1). 43–49.
14.
Khazaei, Hossein Ali, et al.. (2004). Major histocompatibility complex class I and II antigens frequencies in Baloch ethnic group living in the southeast region of Iran. Transplantation Proceedings. 36(5). 1302–1304. 5 indexed citations
15.
Jamshidi, Ahmadreza, et al.. (2003). COMPARISON OF VALIDITY OF MICROLYMPHOCYTOTOXICITY AND FLOWCYTOMETRY METHODS WITH PCR FOR HLA-B27 ANTIGEN TYPING. The Medical Journal of The Islamic Republic of Iran. 17(1). 75–80. 2 indexed citations
16.
Foroutan, Hamid Reza, et al.. (2001). ULCERATIVE COLITIS AND HLA CLASS II PHENOTYPING IN IRAN. The Medical Journal of The Islamic Republic of Iran. 15(1). 7–10. 1 indexed citations
18.
Nikbin, B, et al.. (1979). HLA AW19, B12 in immunoproliferative small intestinal disease.. Gut. 20(3). 226–228. 15 indexed citations
19.
Massoud, Amir Hossein, et al.. (1978). A study of cell-mediated immunity and histocompatibility antigens in leprosy patients in Iran.. Munich Personal RePEc Archive (Ludwig Maximilian University of Munich). 46(2). 149–53. 9 indexed citations
20.
Nikbin, B, D. A. Brewerton, David C. James, & J R Hobbs. (1976). Diminished mixed lymphocyte reaction in ankylosing spondylitis, relatives, and normal individuals all with HL-A 27.. Annals of the Rheumatic Diseases. 35(1). 37–39. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026